JCO Oncology Practice Podcast

JCO Oncology Practice podcasts bring you observations and commentaries in a convenient audio format. This popular feature provides further insight and depth to JCO OP's written articles. Play them on your desktop or download them to your portable MP3 player. JCO OP podcasts are ideal for the clinician on the go—you can keep up to date while you are exercising or driving.

Note to authors: To cite a podcast, authors should use the following format, using the podcaster's name in the place of the author: "Smith KH: Role of Tamoxifen in Breast Cancer Treatment [podcast]. J Oncol Pract doi:10.1200/OP.20.55.5555".

Disclaimer:

The purpose of each podcast is to educate and to inform. The podcast is provided on the understanding that it does not constitute medical or other professional advice or services. It is no substitute for professional care by a doctor or other qualified medical professional and is not intended for use in the diagnosis or treatment of individual conditions. Guests who speak in a podcast express their own opinions, experience, and conclusions. Neither American Society of Clinical Oncology nor any of its affiliates endorses, supports, or opposes any particular treatment option or other matter discussed in a podcast. The mention of any product, service, organization, activity, or therapy on a podcast should not be construed as an ASCO endorsement.

2025 ASCO Quality: Creating a Statewide Cancer Drug Repository Network to Improve Access and Affordability

Oct 11, 2025

Dr. Chino welcomes Dr. Emily Mackler, PharmD, BCOP, the Co-founder and Chief Medical Officer of the YesRx program and an Adjunct Clinical Associate Professor at the University of Michigan. The YesRx program has saved patients in Michigan more than 17 million dollars in the past 2 years. Dr. Mackler's article, "

“Mainstreaming” Germline Genetic Testing: How Nongenetics Providers Can Help Fill the Workforce Gap

Sep 15, 2025

Germline genetic testing can play an essential role in identifying cancer risk, guiding treatment decisions, and informing screening and/or preventive strategies for both patients and patient family members. Access to timely and convenient genetic testing can be challenging based on increased indications for testing,...

Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions

Aug 18, 2025

An estimated 85k adolescents and young adults (AYAs) between the ages of 15 to 39 will be diagnosed with cancer in the United States this year. AYAs with advanced cancer face care gaps for psychosocial support and communication. A recent paper published in JCO OP titled “Promoting Resilience in Stress Management: A...

Incomplete Reporting and Toxicity-Minimizing Language in Oncology

Jul 21, 2025

There is often a disconnect in toxicity assessment between what is reported on clinical trials as being “well tolerated” and the lived experience of taking a treatment for patients. Toxicity minimizing language including “safe” and “tolerable” are subjective and can downplay quality of life limiting side...

Park the Parking: Patient and Caregiver Perspectives on Transportation Barriers in Cancer

Jun 16, 2025

Frustrations regarding the costs and difficulties with parking at hospitals is a common concern voiced by patients, families, and healthcare providers. Transportation barriers to receiving cancer care are incredibly common despite what appears to be relatively straightforward solutions. Dr. Chino welcomes two...